regulatory approval

Nuclear startup Oklo received key DOE regulatory approvals for its Aurora Powerhouse design but stock plummeted 20%, remaining down 70% from 2025 highs amid investor skepticism.

ING cancels sale of Russian subsidiary to Global Development JSC over regulatory hurdles. Bank expects modest 7 basis point CET1 impact from alternative exit.

OceanFirst and Flushing gain shareholder approval for merger; state and OCC regulators approve. Federal Reserve clearance required before completion.

OceanFirst and Flushing Financial gain shareholder approval for merger. Federal Reserve approval and standard closing conditions remain pending before transaction completion.

Brink's expands credit facility to $3.85B to fund NCR Atleos acquisition, subject to regulatory and shareholder approvals.

Brink's expanded credit facility to $3.85B from $2.225B to fund planned $6.6B acquisition of NCR Atleos, pending regulatory approval.

Atara Biotherapeutics faces securities fraud class action for allegedly misrepresenting manufacturing capabilities and overstating regulatory prospects for tabelecleucel between May 2024 and January 2026.

Opus Genetics secures $155M non-dilutive funding from Oberland Capital, extending cash runway through 2029 and accelerating gene therapy development for inherited retinal diseases.

Rosen Law Firm urges Inovio investors with $100K+ losses to file by April 7 deadline in securities class action alleging false manufacturing and regulatory statements.

uniQure faces securities investigation after FDA publicly disputed the company's claims about regulatory guidance for gene therapy candidate AMT-130, with April 2026 deadline for investor class action.

Viking Therapeutics' VK2735 targets the $100+ billion weight-loss market. Success could drive massive stock appreciation, but clinical and competitive risks remain substantial.

BKH and NWE shareholders approve all-stock merger creating Bright Horizon Energy, an eight-state regional utility expected to close H2 2026 pending regulatory approval.

Philips appoints Chief Medical Officer Dr. Carla Goulart Peron to MDIC board, strengthening industry influence over FDA medical device regulatory standards.

CVB Financial ($CVBF) secures regulatory approval for Heritage Commerce ($HTBK) merger, expected to close April 17, 2026, creating stronger California banking entity.

Co-Diagnostics ($CODX) posted $0.6M revenue and $46.9M net loss in 2025, down from prior year, amid strategic joint ventures and pipeline advancement.

Rocket Lab secures German approval for Mynaric acquisition, expected to close in April. Deal expands capabilities in laser communications and provides European footprint.

Rocket Lab wins German regulatory approval to acquire laser communications specialist Mynaric, establishing European headquarters and expanding into high-margin space infrastructure.

Legato Merger Corp. III's auditors raised going concern doubts in latest audit, though company proceeds with Einride AB merger targeting H1 2026 NYSE listing.

Rocket Lab gains German approval to acquire laser communications specialist Mynaric, establishing first European operations and expanding into high-margin satellite infrastructure.

Tesla stock faces potential April 2026 catalyst convergence: delivery growth, Cybercab production acceleration, and potential EU autonomous driving approval.